A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Status
- RECRUITING
- Phase
- PHASE1
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy
- Status
- COMPLETED
- Phase
- NA
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC
- Status
- TERMINATED
- Phase
- PHASE2